Abstract:Microvillus inclusion disease (MVID) is a congenital disorder characterized by severe diarrhea that presents within the first days of life. Inactivating mutations of a motor protein, myosin Vb (MYO5B), have been identified as a cause of MVID. Although a majority of MVID patients carry compound heterozygous mutations, all previously established in vivo MVID models carry homozygous mutations or deletion of MYO5B. We identified a novel set of MYO5B mutations in an MVID patient: a G519R point mutation and another that leads to early truncation. To better understand the pathogenesis of MVID from compound heterozygous mutations, we generated a mouse strain carrying this patient-based mutation.To avoid early lethality by a homozygous Myo5b G519R mutation, we employed the one-step two-cell embryo microinjection (OSTCM) method, that ensures at partial WT Myo5b contribution by inducing CRISPR-mediated mutations in only one cell of two-cell stage mouse embryos. A chimeric founder was backcrossed with wildtype, and generated progeny heterozygous for the Myo5b G519R allele. To complete the modeling of the patient’s mutation, we crossbred a sequence-verified N1 Myo5b G519R/+ mouse with the tamoxifen-inducible intestinal epithelial-directed Villin-Cre ERT 2 ;Myo5b flox/ flox mouse to produce VilCre ERT2 ;Myo5b G519R/ flox (Myo5b(G519R)) mice. In the G519R patient’s duodenal biopsy, enterocytes lacked DPP4+ mature brush border and Actinin-4+ terminal web structure. Multiplexed immunofluorescence analyses on the G519R patient biopsy revealed a lack of GLUT2-expressing mature enterocytes and accumulation of MYO5B together with RAB11A in the cytoplasm. Adult Myo5B(G519R) mice demonstrated a severe, watery diarrheal phenotype 4 days after the tamoxifen injection. The Myo5B(G519R) mouse intestine illustrated various characteristic features of MVID, such as microvillus inclusions, villus blunting, and subapical accumulation of PAS+ vesicles in the enterocytes. Like the G519R patient, immunostaining in the small intestine of Myo5b(G519R) mice demonstrated a mis-localization of apical nutrient transporters and cytoplasmic accumulation of Myo5b with Rab11a. Electron microscopy revealed the shortened, disorganized microvilli on enterocytes of both the villus and crypt. The crypts of Myo5b(G519R) mouse small intestine were elongated compared to control, mirrored by an expansion of PCNA+, EdU+, and OLFM4+ epithelial cell regions. This study provides a novel MVID patient-mimicking mouse model with compound heterozygous mutations in MYO5B and demonstrates the utility of combining the OSTCM and Cre/ loxp systems for modeling deadly monogenic congenital diseases, like MVID. NSF GRFP, NIH R01DK128190, RC2DK118640 This is the full abstract presented at the American Physiology Summit 2023 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

Altered cellular metabolic pathway and epithelial cell maturation induced by MYO5B defects are partially reversible by LPAR5 activation

Alterations in cellular metabolic pathway and epithelial cell maturation induced by MYO5B defects are partially reversible by LPAR5 activation

A Novel mouse model derived from an uncharacterized MVID patient MYO5B mutation

Myo5b knockout mice as a model of microvillus inclusion disease

[Clinical Features and MYO5B Mutations of a Family Affected by Microvillus Inclusion Disease].

MYO5B gene mutations may promote the occurrence of very early onset inflammatory bowel disease: a case report

Two Cases of Microvillus Inclusion Disease Caused by MYO5B Deficiency with Prenatal Abnormalities.

A Molecular Mechanism Underlying Genotype‐Specific Intrahepatic Cholestasis Resulting from MYO5B Mutations

Loss Of Lmod1 Impairs Smooth Muscle Cytocontractility And Causes Megacystis Microcolon Intestinal Hypoperistalsis Syndrome In Humans And Mice

Defects in myosin VB are associated with a spectrum of previously undiagnosed low γ-glutamyltransferase cholestasis.

[Phenotypic and genetic analysis of a family affected with microvillus inclusion disease].

Case Report: MYO5B Homozygous Variant c.2090+3A>T Causes Intron Retention Related to Chronic Cholestasis and Diarrhea

Myosin Vb Traffics P-Glycoprotein to the Apical Membrane of Intestinal Epithelial Cells

Unequal effects of MYO5B mutations in liver and intestine determine the clinical presentation of low-GGT cholestasis.

<i>MYO5B</i>-associated diseases: Novel liver-related variants and genotype-phenotype correlation

IDDF2024-ABS-0412 Intestinal NLRP3 Deficiency Aggravates MASLD Mice Via Reduced Butyrate Production

MYO5B ‐associated diseases: Novel liver‐related variants and genotype‐phenotype correlation

Histopathological Defects in Intestine in Severe Spinal Muscular Atrophy Mice Are Improved by Systemic Antisense Oligonucleotide Treatment

Bacterial lipoate protein ligases rescue lipoylation and respiration deficiency in mammals

Unequal Effects Of Myosin 5b Mutations In Liver And Intestine Determine The Clinical Presentation Of Low-Gamma-Glutamyltransferase Cholestasis

Loss-of-function variants within LMOD1 actin-binding site 2 cause pediatric intestinal pseudo-obstruction by impairing protein stability and actin nucleation